港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

藥明合聯

62.800

-1.650-2.56%

成交量：645.25萬

成交額：4.04億

市值：790.02億

市盈率：62.68

高：64.400

開：64.300

低：62.000

收：64.450

52周最高：85.500

52周最低：24.700

股本：12.58億

香港流通股本：12.58億

量比：1.91

換手率：0.51%

股息：- -

股息率：- -

每股收益(LYR):1.002

淨資產收益率：19.76%

總資產收益率：9.04%

市淨率：9.46

市盈率(LYR):62.68

市銷率: 13.83

資料載入中...

總覽公司新聞資訊公告

31億港元！藥明合聯擬溢價99%收購東曜藥業，ADC產能有望進一步拓展

港股藥企接連開啓併購，藥明合聯擬吞下東曜藥業

醫藥CXO在新分子需求的驅動下，業績將持續超預期

【券商聚焦】交銀國際：JPM醫藥大會有望繼續催化板塊行情

BRIEF-中國藥明生物稱子公司藥明合聯擬控股收購東曜藥業，每股作價4港元

【灣區早參】深圳成全國通勤效率第一超大城市；廣州多家房企確認上周已座談

隔夜美股集體收跌，機構：對中短期港股走勢保持謹慎樂觀

腾讯自选股综合

智通港股早知道 | 財政部召開財政金融協同促內需會議白宮宣佈對特定半導體等加徵25%關税

撿個大漏？每股4港元，藥明系收購東曜藥業

藥明合聯：25年業績強勁增長全球擴張鞏固市場領導力_業績預覽

業績盈喜, 控股收購東曜藥業，藥明合聯(02268)進一步穩固ADC CDMO市場地位

港股公告掘金 | 東曜藥業-B獲藥明合聯溢價約99%提現金要約 1月15日復牌

東曜藥業-B(01875)獲藥明合聯(02268)溢價約99%提現金要約 1月15日復牌

藥明合聯(02268)發盈喜預計2025年度淨利潤按年增長超38%

藥明合聯：正面盈利預告

香港交易所

每日沽空追蹤 | 藥明合聯 01月14日沽空量成交23.7萬股，沽空比例為4.09%

大行評級｜瑞銀：重申藥明合聯「買入」評級去年新增項目量勝預期

國金證券：國內創新藥已步入全面收穫時代，把握優質賽道與出海主線

三生製藥等：MSCI醫療指數漲11.8%，推薦買入

BD大單扎堆、龍頭業績預增翻倍，港A創新藥掀起暴漲浪潮

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02268/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02268","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02268\",,,,,undefined,":{"symbol":"02268","market":"HK","secType":"STK","nameCN":"藥明合聯","latestPrice":62.8,"timestamp":1769760484002,"preClose":64.45,"halted":0,"volume":6452454,"delay":0,"changeRate":-0.0256012412723042,"floatShares":1258000000,"shares":1258000000,"eps":1.0019577166242328,"marketStatus":"休市中","change":-1.65,"latestTime":"01-30 16:08:04","open":64.3,"high":64.4,"low":62,"amount":404425785,"amplitude":0.037238,"askPrice":62.8,"askSize":20000,"bidPrice":62.75,"bidSize":13000,"shortable":3,"etf":0,"ttmEps":1.1457398860998735,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1769995800000},"marketStatusCode":7,"adr":0,"listingDate":1700150400000,"exchange":"SEHK","adjPreClose":64.45,"openAndCloseTimeList":[[1769736600000,1769745600000],[1769749200000,1769760000000]],"volumeRatio":1.914750231084302,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02268\",,,,,undefined,":{"symbol":"02268","floatShares":1258000000,"roa":"9.04%","roe":"19.76%","lyrEps":1.001958,"volumeRatio":1.914750231084302,"shares":1258000000,"dividePrice":0,"high":64.4,"amplitude":0.037238,"preClose":64.45,"low":62,"week52Low":24.7,"pbRate":"9.46","psRate":"13.83","week52High":85.5,"institutionHeld":0,"latestPrice":62.8,"committee":-0.212121,"eps":1.0019577166242328,"divideRate":0,"volume":6452454,"delay":0,"ttmEps":1.1457398860998735,"open":64.3,"prevYearClose":60.75,"prevWeekClose":68.65,"prevMonthClose":62.8,"prevQuarterClose":60.75,"fiveDayClose":68.65,"twentyDayClose":61.35,"sixtyDayClose":70.3},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02268\",params:#limit:5,,,undefined,":[{"date":"2026-03-23","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774229400000,"name":null,"time":"","dateTimestamp":1774195200000,"actualEps":null},{"date":"2025-08-18","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755480600000,"name":null,"time":"","dateTimestamp":1755446400000,"actualEps":null},{"date":"2025-03-24","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-20","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724117400000,"name":null,"time":"","dateTimestamp":1724083200000,"actualEps":null},{"date":"2024-03-25","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02268\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02268\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3,"buy":0.65,"hold":0.05,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.65,"analysts":20,"updateTime":1763740800000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02268\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02268","date":"2026-01-30","current":54.811743,"percent":0.316176,"low":30.568632,"twenty":44.673253,"median":58.945496,"eighty":72.939295,"high":153.052589,"avg":64.806697,"sd":26.709985,"marketCap":79001941874},"quantilePoints":[{"date":"2023-11-17","current":130.035431,"twenty":0.435785,"median":0.444801,"eighty":2.787891,"marketCap":32996488000},{"date":"2023-11-24","current":133.579843,"twenty":0.435785,"median":0.444801,"eighty":2.810425,"marketCap":34174934000},{"date":"2023-12-01","current":147.707211,"twenty":0.435785,"median":0.444801,"eighty":2.852893,"marketCap":37945961200},{"date":"2023-12-08","current":132.646927,"twenty":0.435785,"median":0.444801,"eighty":2.935117,"marketCap":33939244800},{"date":"2023-12-15","current":138.75437,"twenty":0.435785,"median":0.444801,"eighty":3.039251,"marketCap":35706913800},{"date":"2023-12-22","current":153.052589,"twenty":0.435785,"median":0.444801,"eighty":3.172504,"marketCap":39360096400},{"date":"2023-12-29","current":145.85951,"twenty":0.435785,"median":0.444801,"eighty":3.326638,"marketCap":37710272000},{"date":"2024-01-05","current":142.305018,"twenty":0.435785,"median":0.444801,"eighty":3.599996,"marketCap":36531826000},{"date":"2024-01-12","current":138.558869,"twenty":0.435785,"median":0.444801,"eighty":3.622774,"marketCap":35589069200},{"date":"2024-01-19","current":141.046625,"twenty":0.435785,"median":0.444801,"eighty":3.635946,"marketCap":36178292200},{"date":"2024-01-26","current":116.23004,"twenty":0.435785,"median":0.444801,"eighty":3.642902,"marketCap":29696839200},{"date":"2024-02-02","current":82.111439,"twenty":0.435785,"median":0.444801,"eighty":3.654128,"marketCap":20952769880},{"date":"2024-02-09","current":67.278987,"twenty":0.435825,"median":0.445043,"eighty":3.68657,"marketCap":17252449440},{"date":"2024-02-16","current":66.713097,"twenty":0.435798,"median":0.44487,"eighty":3.704054,"marketCap":17111035920},{"date":"2024-02-23","current":82.124312,"twenty":0.435798,"median":0.44487,"eighty":3.728385,"marketCap":20952769880},{"date":"2024-03-01","current":86.135235,"twenty":0.435812,"median":0.444939,"eighty":3.767614,"marketCap":21989802360},{"date":"2024-03-08","current":96.662972,"twenty":0.435812,"median":0.444939,"eighty":3.804363,"marketCap":24688443700},{"date":"2024-03-15","current":72.134287,"twenty":0.435812,"median":0.444939,"eighty":3.87411,"marketCap":18407326520},{"date":"2024-03-22","current":82.739174,"twenty":0.435812,"median":0.444939,"eighty":3.907844,"marketCap":21094183400},{"date":"2024-03-28","current":70.236298,"twenty":0.435812,"median":0.444939,"eighty":3.924107,"marketCap":21565561800},{"date":"2024-04-05","current":69.514463,"twenty":0.435772,"median":0.444721,"eighty":3.932321,"marketCap":21329872600},{"date":"2024-04-12","current":72.929575,"twenty":0.435785,"median":0.444801,"eighty":3.970214,"marketCap":22390474000},{"date":"2024-04-19","current":66.691535,"twenty":0.435785,"median":0.444801,"eighty":4.01279,"marketCap":20457822560},{"date":"2024-04-26","current":78.851628,"twenty":0.435812,"median":0.444939,"eighty":62.837086,"marketCap":24158143000},{"date":"2024-05-03","current":79.483533,"twenty":0.435812,"median":0.444939,"eighty":66.70016,"marketCap":24334909900},{"date":"2024-05-10","current":73.189732,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":22461180760},{"date":"2024-05-17","current":65.221538,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":19986444160},{"date":"2024-05-24","current":58.278715,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":17818103520},{"date":"2024-05-31","current":59.948577,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":18347300940},{"date":"2024-06-07","current":58.299117,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":17820354960},{"date":"2024-06-14","current":64.156468,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":19592809620},{"date":"2024-06-21","current":70.500097,"twenty":0.435812,"median":0.444939,"eighty":69.593748,"marketCap":21485024730},{"date":"2024-06-28","current":68.013259,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":20718557850},{"date":"2024-07-05","current":61.893714,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":18850294830},{"date":"2024-07-12","current":63.530585,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":19377240810},{"date":"2024-07-19","current":56.933019,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":17365265250},{"date":"2024-07-26","current":56.800526,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":17389217340},{"date":"2024-08-02","current":69.358964,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":21221551740},{"date":"2024-08-09","current":72.710245,"twenty":0.435812,"median":0.444939,"eighty":70.597189,"marketCap":22395204150},{"date":"2024-08-16","current":74.003491,"twenty":0.435812,"median":0.444939,"eighty":70.930659,"marketCap":22802389680},{"date":"2024-08-23","current":35.050376,"twenty":0.435812,"median":0.44524,"eighty":71.736965,"marketCap":22742129354},{"date":"2024-08-30","current":36.779427,"twenty":0.435812,"median":0.445278,"eighty":71.736965,"marketCap":24024219892},{"date":"2024-09-06","current":36.193339,"twenty":0.435812,"median":0.445278,"eighty":71.736965,"marketCap":23652773101},{"date":"2024-09-13","current":36.950123,"twenty":0.435812,"median":0.445611,"eighty":71.736965,"marketCap":24084130665},{"date":"2024-09-20","current":36.912594,"twenty":0.435798,"median":0.445732,"eighty":71.812082,"marketCap":24203952211},{"date":"2024-09-27","current":41.596291,"twenty":0.435798,"median":0.446064,"eighty":71.812082,"marketCap":27439133942},{"date":"2024-10-04","current":49.267448,"twenty":0.435798,"median":0.446181,"eighty":71.812082,"marketCap":32351817312},{"date":"2024-10-10","current":43.61955,"twenty":0.435812,"median":0.446472,"eighty":71.736965,"marketCap":28457617080},{"date":"2024-10-18","current":43.201999,"twenty":0.435798,"median":0.446694,"eighty":71.812082,"marketCap":28038241670},{"date":"2024-10-25","current":43.020102,"twenty":0.435798,"median":0.446852,"eighty":71.812082,"marketCap":27918420124},{"date":"2024-11-01","current":41.699543,"twenty":0.435798,"median":0.446999,"eighty":71.812082,"marketCap":27079669305},{"date":"2024-11-08","current":47.130705,"twenty":0.435852,"median":0.447279,"eighty":71.812082,"marketCap":30374761809},{"date":"2024-11-15","current":46.740281,"twenty":0.435852,"median":0.44753,"eighty":71.812082,"marketCap":29895475627},{"date":"2024-11-22","current":46.01742,"twenty":0.435852,"median":0.447785,"eighty":71.812082,"marketCap":29416189444},{"date":"2024-11-29","current":51.670123,"twenty":0.435852,"median":0.448371,"eighty":71.812082,"marketCap":33010835812},{"date":"2024-12-06","current":54.048034,"twenty":0.435852,"median":0.449445,"eighty":71.812082,"marketCap":34448694360},{"date":"2024-12-13","current":58.707371,"twenty":0.435852,"median":0.45138,"eighty":71.812082,"marketCap":37384322227},{"date":"2024-12-20","current":60.54506,"twenty":0.435852,"median":35.016583,"eighty":71.812082,"marketCap":38342894592},{"date":"2024-12-27","current":58.22519,"twenty":0.435852,"median":35.863906,"eighty":71.812082,"marketCap":36845125272},{"date":"2025-01-03","current":57.033249,"twenty":0.435852,"median":36.241161,"eighty":71.812082,"marketCap":36126195998},{"date":"2025-01-10","current":62.66188,"twenty":0.435852,"median":36.730689,"eighty":71.812082,"marketCap":39541110048},{"date":"2025-01-17","current":54.642634,"twenty":0.436361,"median":37.212991,"eighty":71.812082,"marketCap":34508605132},{"date":"2025-01-24","current":54.868028,"twenty":0.436606,"median":39.470644,"eighty":71.812082,"marketCap":34868069769},{"date":"2025-01-28","current":52.331181,"twenty":0.436643,"median":41.238065,"eighty":71.736965,"marketCap":33430211222},{"date":"2025-02-07","current":57.910706,"twenty":0.437089,"median":42.380717,"eighty":71.8872,"marketCap":36785214499},{"date":"2025-02-14","current":56.82028,"twenty":0.437089,"median":43.020102,"eighty":71.8872,"marketCap":36006374452},{"date":"2025-02-21","current":70.802488,"twenty":0.437089,"median":44.139364,"eighty":71.8872,"marketCap":45112811918},{"date":"2025-02-28","current":60.65941,"twenty":0.437089,"median":45.078416,"eighty":71.8872,"marketCap":38522626910},{"date":"2025-03-07","current":67.088057,"twenty":0.437583,"median":46.607669,"eighty":71.962317,"marketCap":42776291779},{"date":"2025-03-14","current":72.98104,"twenty":0.438098,"median":47.703312,"eighty":71.990989,"marketCap":46550670465},{"date":"2025-03-21","current":80.244903,"twenty":0.438098,"median":49.592986,"eighty":72.978175,"marketCap":51163799971},{"date":"2025-03-28","current":47.906694,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":54840613248},{"date":"2025-04-03","current":43.121995,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":49380552191},{"date":"2025-04-11","current":35.581021,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":40380451549},{"date":"2025-04-17","current":33.597127,"twenty":0.4381,"median":49.700845,"eighty":72.980467,"marketCap":38220427395},{"date":"2025-04-25","current":39.226609,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":44663120338},{"date":"2025-05-02","current":40.829264,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":46586700218},{"date":"2025-05-09","current":38.818219,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":44603008467},{"date":"2025-05-16","current":39.608151,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":45882474676},{"date":"2025-05-23","current":38.196121,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":44379117053},{"date":"2025-05-30","current":41.172242,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":48047309655},{"date":"2025-06-06","current":42.866418,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":50152010328},{"date":"2025-06-13","current":46.041552,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":53888090995},{"date":"2025-06-20","current":41.240748,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":48174509918},{"date":"2025-06-27","current":40.971553,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":47994081042},{"date":"2025-07-04","current":46.000985,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":53888090995},{"date":"2025-07-11","current":47.288014,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":55339986740},{"date":"2025-07-18","current":50.925924,"twenty":0.438098,"median":50.569275,"eighty":72.98104,"marketCap":59550637905},{"date":"2025-07-25","current":57.660678,"twenty":0.438098,"median":51.683826,"eighty":72.98104,"marketCap":67671179437},{"date":"2025-08-01","current":57.245588,"twenty":0.438098,"median":52.545804,"eighty":72.98104,"marketCap":66768897045},{"date":"2025-08-08","current":57.73965,"twenty":0.43811,"median":53.257543,"eighty":72.98104,"marketCap":67513611340},{"date":"2025-08-15","current":64.222783,"twenty":31.309336,"median":54.856958,"eighty":72.98104,"marketCap":74981664691},{"date":"2025-08-22","current":48.130228,"twenty":34.419063,"median":54.952855,"eighty":72.98104,"marketCap":69501077151},{"date":"2025-08-29","current":46.988345,"twenty":35.581021,"median":54.952855,"eighty":72.98104,"marketCap":68176099944},{"date":"2025-09-05","current":54.370406,"twenty":36.186031,"median":55.113399,"eighty":72.98104,"marketCap":78808670381},{"date":"2025-09-12","current":57.034752,"twenty":36.596757,"median":55.50873,"eighty":72.98104,"marketCap":82819396110},{"date":"2025-09-19","current":59.571504,"twenty":36.911418,"median":56.000464,"eighty":72.98104,"marketCap":86441593568},{"date":"2025-09-26","current":63.204858,"twenty":37.279949,"median":56.495601,"eighty":72.98104,"marketCap":91475834102},{"date":"2025-10-03","current":72.025865,"twenty":37.670679,"median":56.699916,"eighty":72.980467,"marketCap":104491187679},{"date":"2025-10-10","current":60.90024,"twenty":38.189538,"median":56.97042,"eighty":72.98104,"marketCap":88221995708},{"date":"2025-10-17","current":57.936353,"twenty":38.732076,"median":57.121577,"eighty":72.98104,"marketCap":83863080123},{"date":"2025-10-24","current":59.821834,"twenty":39.226609,"median":57.526112,"eighty":72.98104,"marketCap":86623810506},{"date":"2025-10-31","current":63.630196,"twenty":39.774995,"median":57.92353,"eighty":72.98104,"marketCap":92275860553},{"date":"2025-11-07","current":58.827143,"twenty":40.354886,"median":58.251953,"eighty":72.98104,"marketCap":85257233036},{"date":"2025-11-14","current":59.953959,"twenty":41.172242,"median":58.455089,"eighty":72.98104,"marketCap":87136525462},{"date":"2025-11-21","current":57.356344,"twenty":41.596291,"median":58.554061,"eighty":72.98104,"marketCap":83322340564},{"date":"2025-11-28","current":56.291024,"twenty":42.018405,"median":58.564991,"eighty":72.98104,"marketCap":82071768197},{"date":"2025-12-05","current":57.95451,"twenty":42.42494,"median":58.564991,"eighty":72.98104,"marketCap":84642388897},{"date":"2025-12-12","current":56.819112,"twenty":42.866418,"median":58.860686,"eighty":72.98104,"marketCap":83137635317},{"date":"2025-12-19","current":59.902097,"twenty":43.024716,"median":58.930609,"eighty":72.98104,"marketCap":87855221510},{"date":"2025-12-24","current":53.787136,"twenty":43.211711,"median":58.930609,"eighty":72.98104,"marketCap":79132453088},{"date":"2026-01-02","current":52.131715,"twenty":43.875774,"median":58.940897,"eighty":73.022778,"marketCap":76998826280},{"date":"2026-01-09","current":60.097118,"twenty":44.079539,"median":58.920321,"eighty":72.979321,"marketCap":88984788643},{"date":"2026-01-16","current":59.868148,"twenty":44.329264,"median":59.011667,"eighty":72.978748,"marketCap":88933823858},{"date":"2026-01-23","current":58.064858,"twenty":44.542103,"median":59.011667,"eighty":72.978748,"marketCap":86172293688},{"date":"2026-01-30","current":52.991062,"twenty":44.673253,"median":58.945496,"eighty":72.939295,"marketCap":79001941874}],"updateTime":1769867018266},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02268\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2603867929","title":"31億港元！藥明合聯擬溢價99%收購東曜藥業，ADC產能有望進一步拓展","url":"https://stock-news.laohu8.com/highlight/detail?id=2603867929","media":"澎湃新闻","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603867929?lang=zh_tw&edition=fundamental","pubTime":"2026-01-15 15:13","pubTimestamp":1768461189,"startTime":"0","endTime":"0","summary":"国内CXO行业再现大手笔收购。1月14日晚间，药明生物（2269.HK）、药明生物附属公司药明合联（2268.HK）及东曜药业（1875.HK）发布联合公告称，药明合联通过财务顾问花旗环球金融亚洲有限公司，向东曜药业发出自愿有条件现金要约，拟收购其全部已发行股份（要约人及一致行动人士已持有或同意收购的股份除外），并注销全部尚未行使购股权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601153620361651.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601153620361651.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["SG9999014674.SGD","ADC","BK4080","02268","BK4231","LU2488822045.USD","BK1141"],"gpt_icon":0},{"id":"2603676889","title":"港股藥企接連開啓併購，藥明合聯擬吞下東曜藥業","url":"https://stock-news.laohu8.com/highlight/detail?id=2603676889","media":"第一财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603676889?lang=zh_tw&edition=fundamental","pubTime":"2026-01-15 14:25","pubTimestamp":1768458352,"startTime":"0","endTime":"0","summary":"在中国生物制药宣布全资收购小核酸创新药企赫吉亚后的第二天，港股药企的又一起并购接踵而至。1月14日晚间，药明合联（02268.HK）发布了拟溢价约99%要约收购东曜药业消息。要约收购价每股为4港元，要约收购达成的条件之一，收购的股份可以使得药明合联持有东曜药业的投票权不低于60%。药明合联这次要约收购，将最高耗资27.9亿港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601153620324032.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"a4cd798a0dc63451f8e31d3f6cbd021e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601153620324032.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2488822045.USD","02268","BK1141","SG9999014674.SGD"],"gpt_icon":0},{"id":"2603704806","title":"醫藥CXO在新分子需求的驅動下，業績將持續超預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2603704806","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603704806?lang=zh_tw&edition=fundamental","pubTime":"2026-01-15 09:23","pubTimestamp":1768440220,"startTime":"0","endTime":"0","summary":"外需型CXO在新分子需求的驱动下，业绩持续超预期，有望和创新药实现共振。其中，药明康德等CXO头部企业的盈利预喜亦持续验证增长逻辑。展望未来，随着流动性修复持续深化，创新药β行情的确定性不断增强，而CXO板块作为创新药研发的核心配套产业，将充分享受行业景气度提升的红利。外需型CXO凭借新分子领域的竞争优势，有望与创新药板块形成共振增长；内需型CXO则有望在订单回暖的基础上实现业绩反转，板块分化中孕育多元投资机会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115093755a71c39c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115093755a71c39c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","LU2488822045.USD","BK1161","SG9999014674.SGD","02268","BK1515","02359","BK1141","BK1574"],"gpt_icon":0},{"id":"2603626967","title":"【券商聚焦】交銀國際：JPM醫藥大會有望繼續催化板塊行情","url":"https://stock-news.laohu8.com/highlight/detail?id=2603626967","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603626967?lang=zh_tw&edition=fundamental","pubTime":"2026-01-15 09:09","pubTimestamp":1768439355,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际发布医药行业周报，本周26省联盟药品集采开启，纳入多项国采可替代品种，该机构认为具备成本与渠道优势的头部企业将获益；同时两大进口主导型耗材省际联盟集采启动，国产替代进程有望进一步提速。JPM医药大会将于本周召开，超20家中国公司将出席并发表主题演讲，有望继续催化行情。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1973261","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345770308.USD","LU0640798160.USD","LU0215105999.USD","02367","IE00BWXC8680.SGD","LU1032466523.USD","LU2592432038.USD","09688","LU1496350171.SGD","LU2211815571.USD","BK1593","02196","LU0820561909.HKD","09926","BK1515","LU1988902786.USD","LU1064131342.USD","BK4207","BK1197","02268","LU0868494617.USD","LU0496365809.HKD","01530","IE00BN8TJ469.HKD","LU0307460666.USD","01099","01789","LU2430703095.HKD","LU1116320737.USD","03329","BK4581","LU0942090050.USD","LU0310799852.SGD","LU1280957306.USD","LU1670628061.USD","SG9999004311.SGD","LU0267386448.USD","159938","IE00B5MMRT66.SGD","LU1719994722.HKD","LU2357305700.SGD","09939","BK1141","03933","LU0238689110.USD","06160","LU0211327993.USD","LU2505996681.GBP"],"gpt_icon":0},{"id":"2603162546","title":"BRIEF-中國藥明生物稱子公司藥明合聯擬控股收購東曜藥業，每股作價4港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603162546","media":"路透中文","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603162546?lang=zh_tw&edition=fundamental","pubTime":"2026-01-15 08:44","pubTimestamp":1768437860,"startTime":"0","endTime":"0","summary":"BRIEF-中国药明生物称子公司药明合联拟控股收购东曜药业，每股作价4港元路透1月15日 - WuXi Biologics  Inc 2269.HK:中国药明生物、药明合联2268.HK、东曜药业1875.HK发布联合公告。药明合联将以每股4.00港元的价格向东曜药业提出有条件现金收购要约，收购后者所有约7.73亿股股份。药明合联计划维持东曜药业在香港的上市地位。东曜药业股票将于1月15日恢复交易。药明生物直接持有药明合联已发行股本总额的约50.63%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a4cd798a0dc63451f8e31d3f6cbd021e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nL4S3YG01N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0181495838.USD","LU0326950275.SGD","02269","BK1589","BK1574","LU0823426308.USD","BK1141","LU0359202008.SGD","LU1242518857.USD","LU0516422440.USD","LU1720050803.USD","LU0052750758.USD","LU0140636845.USD","LU0348735423.USD","LU0588546209.SGD","LU0039217434.USD","LU0708995583.HKD","LU0819121731.USD","LU0856984785.SGD","SG9999002463.SGD","SG9999014674.SGD","LU0516422366.SGD","BK1610","BK1161","02268","LU0320764599.SGD","LU0327786744.USD","LU0516423091.SGD","LU0823426480.USD","LU0456846285.SGD","BK1576","LU2488822045.USD","SG9999002562.SGD","LU1794554557.SGD","LU1880383366.USD","LU0417516902.SGD","01875","LU1688375341.USD","LU0979878070.USD","LU0456827905.SGD","LU0572944931.SGD","LU0417516738.SGD","BK1521","LU0348825331.USD","IE00B0JY6N72.USD","LU3063872942.SGD","LU0516422952.EUR","LU2039709279.SGD","LU0043850808.USD","LU1242518931.SGD"],"gpt_icon":0},{"id":"2603625498","title":"【灣區早參】深圳成全國通勤效率第一超大城市；廣州多家房企確認上周已座談","url":"https://stock-news.laohu8.com/highlight/detail?id=2603625498","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603625498?lang=zh_tw&edition=fundamental","pubTime":"2026-01-15 08:40","pubTimestamp":1768437615,"startTime":"0","endTime":"0","summary":"报告指出，深圳45分钟以内通勤比重达到81%，成为全国唯一突破80%“幸福线”的超大城市。记者多方确认，上周广州市住建局已召集金融部门和部分房企就融资问题进行座谈。净亏损的主要原因为于截至2025年12月31日止年度，公司建材及房地产业务均处于行业下行周期。","market":"us","thumbnail":"https://static.szfiu.com/news/20241108/ZTRlMTU1ZDUyYWE0NDQzMjc2MzgzOTI4MA==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZTRlMTU1ZDUyYWE0NDQzMjc2MzgzOTI4MA==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1973253","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1576","LU0051755006.USD","LU1497733631.SGD","03759","02268","BK1135","LU1794554557.SGD","LU2488822045.USD","BK1594","02009","LU0264606111.USD","LU1522347837.USD","BK1564","BK1503","06030","BK1231","LU0572939691.SGD","BK1141","LU1497733557.USD","LU1634259557.SGD","LU1720050803.USD","BK1563","00998","LU1497734951.SGD","LU0456827905.SGD","BK1516","LU0210526637.USD","CYB","SG9999014674.SGD","BK1147","BK1521","UCmain","BK1560","LU1634259391.SGD","LU0572940350.SGD","CNHmain"],"gpt_icon":0},{"id":"2603862802","title":"隔夜美股集體收跌，機構：對中短期港股走勢保持謹慎樂觀","url":"https://stock-news.laohu8.com/highlight/detail?id=2603862802","media":"腾讯自选股综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603862802?lang=zh_tw&edition=fundamental","pubTime":"2026-01-15 07:51","pubTimestamp":1768434698,"startTime":"0","endTime":"0","summary":"周三，美股三大指数集体收跌，其中纳斯达克指数跌幅居前。其中，招商证券指出，上周港股走势滞后A股主因海外流动性博弈。华西证券表示，港股继续跑输A股，人气的恢复需要时间。中期整体判断维持谨慎乐观。我们对于中短期市场走势继续保持谨慎乐观的态度。至此，2026年登陆港交所的新股已达11只。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011507441497a1d855&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011507441497a1d855&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4023","BK4551","BK4561","SPY","AI","06030","HSI","600030","BK4534","01811","BK4550","02268","BK4528","QQQ","BK4581","BK4593","BK4587","BK4588","TQQQ","01875","BK4585","BK4543","00123","CIIHY","HSTECH"],"gpt_icon":0},{"id":"2603462820","title":"智通港股早知道 | 財政部召開財政金融協同促內需會議 白宮宣佈對特定半導體等加徵25%關税","url":"https://stock-news.laohu8.com/highlight/detail?id=2603462820","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603462820?lang=zh_tw&edition=fundamental","pubTime":"2026-01-15 07:40","pubTimestamp":1768434028,"startTime":"0","endTime":"0","summary":"参加会议的包括国务院有关部门和单位、省级财政部门、财政部各地监管局以及相关经办机构。美国白宫宣布对特定半导体等加征25%关税美国白宫14日宣布，从15日起对部分进口半导体、半导体制造设备和衍生品加征25%的进口从价关税。根据该通知书，市监总局已根据中华人民共和国反垄断法开始对本公司进行调查。经本公司财务部门初步测算，预计2025年度实现归属于上市公司股东的扣除","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a7a093e7059d2a399d631855b31ce739","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1393051.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SOXX","BK1617","BK1515","BK1610","BK1615","09688","SMH","LU1720050803.USD","BK1247","BK1516","BK1584","BK1571","WXXWY","BK1564","BK1521","BK1591","09961","BK1147","03759","BK4588","BK1189","BK1501","BK1502","02268","02269","BK4585","ZLAB","BK1142","TCOM","LU1794554557.SGD","BK1589","300759","01875"],"gpt_icon":1},{"id":"2603460746","title":"撿個大漏？每股4港元，藥明系收購東曜藥業","url":"https://stock-news.laohu8.com/highlight/detail?id=2603460746","media":"E药经理人","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603460746?lang=zh_tw&edition=fundamental","pubTime":"2026-01-15 00:20","pubTimestamp":1768407613,"startTime":"0","endTime":"0","summary":"1月14日晚间，药明生物、药明合联、东曜药业联合发布公告，主体内容是花旗环球金融亚洲有限公司代表要约人药明合联，拟以每股4港元现金收购东曜药业全部已发行股份（除已持有或同意收购部分），并以每股1.7665港元注销全部7,632,600份尚未行使购股权。股份要约价较未受干扰日（2025年12月22日）收盘价2.01港元溢价99%，较30日平均收市价1.86港元溢价114.67%，较经审核净资产1.05港元溢价280.79%，体现显著溢价。收购要约核心内容：东曜药业股份自2025年12月29日起暂停买卖，2026年1月14日公告要约方案，拟于2026年1月15日恢复交易。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115002515953ccb65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115002515953ccb65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999014674.SGD","BK1141","LU2488822045.USD","02268"],"gpt_icon":0},{"id":"2603323988","title":"藥明合聯：25年業績強勁增長 全球擴張鞏固市場領導力_業績預覽","url":"https://stock-news.laohu8.com/highlight/detail?id=2603323988","media":"中金公司","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603323988?lang=zh_tw&edition=fundamental","pubTime":"2026-01-15 00:00","pubTimestamp":1768406400,"startTime":"0","endTime":"0","summary":"公司预测收入同比增长超过45%公司发布2025 年业绩预告，收入同比增速超过45%、经调整净利润同比增长超45%。关注要点核心业务保持高速增长，行业龙头地位继续巩固。受益于ADC外包需求持续景气及公司一体化CRDMO平台差异化优势，公司2025 年收入同比增速预计超过45%，毛利增速突破70%，在利润端，扣除利息收支后的经调整净利润同比增幅超45%，若剔除汇率波动影响增速超过65%。战略性收购东曜药业，积极推进全球产能布局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115211329a71ecb7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115211329a71ecb7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","02268","BK1141","SG9999014674.SGD"],"gpt_icon":0},{"id":"2603610556","title":"業績盈喜, 控股收購東曜藥業，藥明合聯(02268)進一步穩固ADC CDMO市場地位","url":"https://stock-news.laohu8.com/highlight/detail?id=2603610556","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603610556?lang=zh_tw&edition=fundamental","pubTime":"2026-01-14 23:32","pubTimestamp":1768404738,"startTime":"0","endTime":"0","summary":"同时，通过此次控股收购，药明合联亦希望进一步丰富其项目组合并扩大其客户群，稳固其在 ADC CDMO 领域的领导地位。药明合联早已布局人才梯队建设，截至2025年底，团队规模已突破2600人。截至2025年12月底，药明合联在全球合作客户数量已超过630家，iCMC项目总数达到252个。这一举措不仅能实现产能的本地化交付，更能进一步深化公司在全球生物偶联药CDMO领域的市场覆盖，巩固行业领先地位。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1393023.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4080","ADC","LU2488822045.USD","SG9999014674.SGD","BK4231","CDMO","BK4139","02268","BK1141"],"gpt_icon":1},{"id":"2603157617","title":"港股公告掘金 | 東曜藥業-B獲藥明合聯溢價約99%提現金要約 1月15日復牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2603157617","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603157617?lang=zh_tw&edition=fundamental","pubTime":"2026-01-14 23:05","pubTimestamp":1768403110,"startTime":"0","endTime":"0","summary":"重大事项：龙旗科技(09611)1月14日至1月19日招股 拟全球发售5225.91万股H股和黄医药(00013)宣布SACHI III期研究结果于《柳叶刀 (The Lancet)》发表东阳光药(06887)推出面向PROTAC机制的AI智能研发平台 持续深化AI战略布局东曜药业-B(01875)获药明合联(02268)溢价约99%提现金要约 1月15日复牌维立志博-B(09887)：维利信(P","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1393019.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0051755006.USD","LU1497733631.SGD","LU0210526637.USD","09887","BK1147","LU1522347837.USD","BK1560","00998","LU1497733557.USD","LU2488822045.USD","SG9999014674.SGD","BK1516","HK0000500386.USD","LU0264606111.USD","BK1141","LU0572940350.SGD","01875","BK1231","LU1720050803.USD","06030","LU0456827905.SGD","LU1634259391.SGD","LU1634259557.SGD","02268","BK1161","LU1497734951.SGD","06887","BK1521","LU1794554557.SGD","BK1191","BK1574","HK0000252160.HKD","LU0572939691.SGD","HK0000252152.HKD","BK1564"],"gpt_icon":0},{"id":"2603617932","title":"東曜藥業-B(01875)獲藥明合聯(02268)溢價約99%提現金要約 1月15日復牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2603617932","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603617932?lang=zh_tw&edition=fundamental","pubTime":"2026-01-14 23:02","pubTimestamp":1768402952,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东曜药业-B 及要约人药明合联联合公布，于2026年1月14日，董事会获要约人告知，花旗将为及代表要约人作出自愿有条件现金要约，以每股要约股份4港元的价格收购全部已发行股份，并注销全部尚未行使购股权。要约价较股份于未受干扰日在联交所所报收市价每股2.01港元溢价约99.00%。公司已向联交所申请自2026年1月15日上午九时正起恢复股份于联交所买卖。要约人拟于完成后维持股份于联交所上市。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1393016.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"东曜药业-B获药明合联溢价约99%提现金要约，1月15日复牌","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","LU2488822045.USD","02268","BK1161","01875","SG9999014674.SGD","BK1574"],"gpt_icon":1},{"id":"2603120296","title":"藥明合聯(02268)發盈喜 預計2025年度淨利潤按年增長超38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603120296","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603120296?lang=zh_tw&edition=fundamental","pubTime":"2026-01-14 22:54","pubTimestamp":1768402472,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药明合联(02268)发布公告，预期集团截至2025年12月31日止年度取得以下财务业绩：(1)收入：较截至2024年12月31日止年度增长超过45%;(2)毛利：较截至2024年12月31日止年度增长超过70%。毛利增长率高于收入增长率，显示集团产品╱服务利润率及成本控制能力的有效优化;(3)扣除利息收入及开支前的经调整纯利：较截至2024年12月31日止年度增长超过45%。撇除汇率变动影响后，该增长率预期将超过65%，证实了集团核心经营业务强劲的利润增长动力;(4)净利润：尽管受到汇率及利率变动的不利影响，较截至2024年12月31日止年度增长超过38%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1393012.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02268"],"gpt_icon":0},{"id":"2603646079","title":"藥明合聯：正面盈利預告","url":"https://stock-news.laohu8.com/highlight/detail?id=2603646079","media":"香港交易所","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603646079?lang=zh_tw&edition=fundamental","pubTime":"2026-01-14 22:50","pubTimestamp":1768402244,"startTime":"0","endTime":"0","summary":"药明合联发布2025年度盈利预告，预计全年业绩将录得显著增长。根据未经审核综合管理账目初步评估，公司2025年度收入预期同比增长超过45%，毛利更将同比增长超过70%，毛利增长率高于收入增长率反映公司产品及服务利润率和成本控制能力得到有效优化。扣除利息收入及开支前的经调整纯利预计同比增长超过45%，若撇除汇率变动影响则增幅将超过65%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115013137a4c42283&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115013137a4c42283&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","02268","SG9999014674.SGD","BK1141"],"gpt_icon":0},{"id":"2603697619","title":"每日沽空追蹤 | 藥明合聯 01月14日沽空量成交23.7萬股，沽空比例為4.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603697619","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603697619?lang=zh_tw&edition=fundamental","pubTime":"2026-01-14 16:30","pubTimestamp":1768379428,"startTime":"0","endTime":"0","summary":"药明合联北京时间01月14日，涨1.54%，卖空量成交23.7万股，较上一交易日减少42.34%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114164208a7196990&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114164208a7196990&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02268","SG9999014674.SGD","LU2488822045.USD","BK1141"],"gpt_icon":0},{"id":"2603668420","title":"大行評級｜瑞銀：重申藥明合聯「買入」評級 去年新增項目量勝預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2603668420","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603668420?lang=zh_tw&edition=fundamental","pubTime":"2026-01-14 10:57","pubTimestamp":1768359422,"startTime":"0","endTime":"0","summary":"瑞银发表研究报告指，基于药明合联领先的生物偶联CRDMO平台地位、产能的持续扩张及地缘政治风险的可控性，重申“买入”评级，目标价为89.5港元。报告提到，药明合联母公司药明生物在2025年新增的209个项目中，逾70个来自药明合联，远高于此前指引的60个以上。此外，公司料未来五年的营收将实现约30%的年复合增长率，增速快于行业平均水平。凭良好的业务记录，药明合联有望继续获取包括北美在内的全球新订单。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260114/31940781.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02268"],"gpt_icon":0},{"id":"2603514436","title":"國金證券：國內創新藥已步入全面收穫時代，把握優質賽道與出海主線","url":"https://stock-news.laohu8.com/highlight/detail?id=2603514436","media":"国金证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603514436?lang=zh_tw&edition=fundamental","pubTime":"2026-01-14 08:02","pubTimestamp":1768348936,"startTime":"0","endTime":"0","summary":"全球及中国生物医药BD合作持续升温，交易数量与金额双升，中国创新药出海进入多品类攻坚阶段，License-out交易成为跨国交易主线。同时，中国创新药研发能力凸显，IND、NDA数量及获批上市品种持续增长，在ADC、细胞疗法等多个赛道在研数量全球领先，FIC分子数量跃居全球第二，中美原研药上市时间差距大幅缩短，国内创新药已步入全面收获时代。内外共振，把握优质赛道与出海主线。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114075809a7178b24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114075809a7178b24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06978","LU0359201612.USD","09606","BK1191","01177","01276","06160","01093","03759","02268","LU1023057109.AUD","LU2543165471.USD","01801","03692","BK1574","LU0359201885.HKD","LU0359202008.SGD","BK1161","09926"],"gpt_icon":0},{"id":"2603680997","title":"三生製藥等：MSCI醫療指數漲11.8%，推薦買入","url":"https://stock-news.laohu8.com/highlight/detail?id=2603680997","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603680997?lang=zh_tw&edition=fundamental","pubTime":"2026-01-13 16:33","pubTimestamp":1768293225,"startTime":"0","endTime":"0","summary":"【招银国际：MSCI中国医疗指数年初至今涨11.8%，推荐买入多只医药股】1月13日，招银国际发布研报称，MSCI中国医疗指数今年初至今累计涨幅达11.8%，跑赢MSCI中国指数9.1%。医药行业显著上涨，是因去年四季度行业回调消化了估值，年初投资者配置意愿较强。 展望2026年，创新药出海趋势将长期延续。该行会重点关注已出海管线的临床进展与数据兑现等核心催化因素，推荐买入三生制药、固生堂、药明合联和中国生物制药。本文由 AI 算法生成，仅作参考，不涉投资建议，使用风险自担","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113214343a4bf2187&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113214343a4bf2187&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1583","BK1521","BK1593","IE00BZ08YR35.GBP","BK1515","02268","BK1191","01530","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","01177","BK1589","HK0000165453.HKD"],"gpt_icon":0},{"id":"2603508160","title":"BD大單扎堆、龍頭業績預增翻倍，港A創新藥掀起暴漲浪潮","url":"https://stock-news.laohu8.com/highlight/detail?id=2603508160","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603508160?lang=zh_tw&edition=fundamental","pubTime":"2026-01-13 14:58","pubTimestamp":1768287489,"startTime":"0","endTime":"0","summary":"创新药出海趋势长期将延续","market":"sg","thumbnail":"https://img3.gelonghui.com/2f9f2-3fe40f69-2e6b-49e8-b3d4-0d701ad6f9ba.jpg?guru_height=718&guru_width=1280&guru_size=93715","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/2f9f2-3fe40f69-2e6b-49e8-b3d4-0d701ad6f9ba.jpg?guru_height=718&guru_width=1280&guru_size=93715"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/3569925","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK0175","BK0060","IE00BZ08YR35.GBP","LU1993786604.SGD","BK0216","LU1960683339.HKD","SG9999014674.SGD","BK1141","LU1064130708.USD","LU1226287529.USD","IE00B031HY20.USD","LU1226287792.SGD","01093","IE00B543WZ88.USD","LU1008478684.HKD","BK1191","LU0501845795.SGD","SG9999004220.SGD","BK1515","LU1951186391.HKD","LU2039709279.SGD","BK0028","IE0008368742.USD","301333","BK1161","LU1064131003.USD","BK1521","BK0188","LU1328277881.USD","LU1807302812.USD","IE00BZ08YS42.EUR","159992","BK0096","LU0314109678.HKD","IE0008369823.USD","LU1152091168.USD","LU0072913022.USD","BK0239","LU0326950275.SGD","LU1813983027.USD","IE00B5MMRT66.SGD","688331","LU1226288253.USD","06955","LU0315179316.USD","600196","02268","BK0196","LU1152091754.HKD","06978"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}